Fig. 5

SUCRA evaluations of the network meta-analysis for observational studies (anti-diabetic agents and the risks of vascular dementia). Abbreviations: TZD, thiazolidinediones; AGI, α-glucosidase inhibitor; DPP-4i, dipeptidyl peptidse-4 inhibitor; SGLT-2i, sodium-glucose cotransporter-2 inhibitor; GLP-1RA, glucagon-like peptide-1 receptor agonist; GKA, glucokinase activator.